Table 1.
Clinical factor | No. | TMEM176Amethylation status | P value | |
---|---|---|---|---|
Unmethylated, n = 31 (24.6%) | Methylated, n = 95 (75.4%) | |||
Age (years) | 0.769 | |||
< 60 | 88 | 21 | 67 | |
≥ 60 | 38 | 10 | 28 | |
Gender | 0.798 | |||
Male | 108 | 27 | 81 | |
Female | 18 | 4 | 14 | |
HBV infection | 0.948 | |||
Yes | 90 | 22 | 68 | |
No | 36 | 9 | 27 | |
Liver cirrhosis | 0.955 | |||
Yes | 93 | 23 | 70 | |
No | 33 | 8 | 25 | |
Tumor size (cm) | 0.242 | |||
> 5 | 84 | 18 | 66 | |
≤ 5 | 42 | 13 | 29 | |
Differentiation | 0.029* | |||
Well or moderate | 68 | 22 | 46 | |
Poor | 58 | 9 | 49 | |
TNM stage | 0.377 | |||
Stage I + stage II | 52 | 14 | 38 | |
Stage III + stage IV | 65 | 13 | 52 | |
Number of lesions | 0.347 | |||
1 | 98 | 26 | 72 | |
≥ 1 | 28 | 5 | 23 | |
Vessel cancerous embolus | 0.599 | |||
Negative | 93 | 24 | 69 | |
Positive | 33 | 7 | 26 | |
Lymph node metastasis | 0.644 | |||
Negative | 120 | 30 | 90 | |
Positive | 6 | 1 | 5 |
P values are obtained from chi-square test, significant difference
*P < 0.05